Investigational Site Number 111 — Las Vegas, Nevada

Investigational Site Number 111 is a clinical research site located in Las Vegas, Nevada, United States 89135.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Investigational Site Number 111 has participated in 1 clinical trials.

Therapeutic areas: Hemophilia A, Hemophilia B.

Sponsors: Genzyme, a Sanofi Company.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Investigational Site Number 111?

Investigational Site Number 111 has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Investigational Site Number 111 conducted?

Investigational Site Number 111 has 1 clinical trials on record. Their work covers Hemophilia A, Hemophilia B.

Is Investigational Site Number 111 accredited by Crixeo Health?

Investigational Site Number 111 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Investigational Site Number 111?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.